GNH USA

Europe — EMA

Leukeran (Chlorambucil)

GNH USA supplies Leukeran (Chlorambucil), an alkylating antineoplastic agent indicated for chronic lymphocytic leukemia and non‑Hodgkin lymphoma.

Chlorambucil

Request sourcing

1
Pack/s

What is Chlorambucil?

Chlorambucil, the active ingredient in Leukeran, is an alkylating agent presented as an oral tablet for oral use. It is employed in the treatment of certain blood cancers, primarily chronic lymphocytic leukemia and non‑Hodgkin lymphoma, in adult patients and is administered under specialist supervision.

GNH USA supplies Leukeran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide, adhering to EU manufacturing standards and providing full batch documentation to ensure product integrity across global markets through rigorous quality controls.

What is Chlorambucil used for?

Leukeran is an alkylating chemotherapy agent used in the management of hematologic malignancies.

- Chronic lymphocytic leukemia: helps control disease progression and prolongs survival. - Non‑Hodgkin lymphoma: contributes to tumor reduction and remission in eligible patients. - Hairy cell leukemia: provides disease control in patients unsuitable for more intensive therapy.

What are the side effects of Chlorambucil?

Leukeran may cause a range of adverse reactions.

Common Side Effects: - Nausea and vomiting. - Loss of appetite. - Fatigue. - Mild leukopenia. - Alopecia. - Diarrhea.

Serious or Rare Side Effects: - Severe bone‑marrow suppression leading to pancytopenia. - Opportunistic infections due to immunosuppression. - Secondary malignancies such as acute leukemia. - Pulmonary toxicity, including interstitial pneumonitis. - Severe allergic reactions (anaphylaxis). - Hepatic dysfunction with elevated transaminases.

What precautions apply to Chlorambucil?

Before initiating Leukeran, several safety measures should be observed.

- Monitor blood counts: perform regular complete blood count assessments. - Assess liver function: obtain baseline and periodic liver enzyme tests. - Avoid use in severe bone‑marrow suppression: contraindicated in patients with existing pancytopenia. - Use effective contraception: potential teratogenic risk warrants reliable birth control. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

What does Chlorambucil interact with?

Leukeran can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Concurrent use with other alkylating agents: may markedly increase myelosuppression. - Live vaccines: heightened risk of infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Myelosuppressive antibiotics (e.g., linezolid): may exacerbate bone‑marrow toxicity. - Anticoagulants such as warfarin: increased bleeding tendency. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may raise risk of gastrointestinal irritation. - Allopurinol: can potentiate chlorambucil toxicity.

Frequently asked questions

What is Leukeran used for?+
Leukeran contains chlorambucil, an alkylating chemotherapy drug used primarily to treat chronic lymphocytic leukemia, non‑Hodgkin lymphoma, and hairy cell leukemia in adult patients. It works by interfering with the DNA of malignant lymphocytes, helping to control disease progression and achieve remission.
How does chlorambucil work?+
Chlorambucil alkylates DNA, creating cross‑links that prevent DNA replication and transcription. This damage triggers cell‑cycle arrest and programmed cell death, especially in rapidly dividing cancer cells, thereby reducing tumor burden in hematologic malignancies.
What is the usual dose of Leukeran?+
The dosing regimen for Leukeran is individualized and set by the prescribing oncologist or hematologist based on the patient’s specific condition, disease stage, and tolerance. Patients should follow the prescriber’s instructions and not alter the dose without medical guidance.
Is Leukeran safe in pregnancy or breastfeeding?+
Safety data for chlorambucil during pregnancy and lactation are limited, and the drug may pose risks to the fetus or infant. It is generally avoided in pregnant or nursing women unless the potential benefit outweighs the risk, and alternative therapies are considered.
How do I order Leukeran from GNH USA?+
To order Leukeran, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Leukeran compare with the main alternative drug or class?+
Leukeran belongs to the alkylating agent class, similar to cyclophosphamide and melphalan. Compared with cyclophosphamide, chlorambucil is administered orally and often has a milder toxicity profile, but both share risks of bone‑marrow suppression and secondary malignancies. Choice depends on disease specifics, patient tolerance and treatment protocol.
How should Leukeran be stored and handled?+
Leukeran tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.
How is Leukeran given or administered?+
Leukeran is taken orally as a tablet with a full glass of water, usually on an empty stomach unless directed otherwise by the prescriber. The exact timing and frequency are determined by the treating physician based on the therapeutic plan.
What are the most serious risks to watch for while taking Leukeran?+
The most serious risks include severe bone‑marrow suppression leading to pancytopenia, opportunistic infections, secondary cancers such as acute leukemia, pulmonary toxicity, and severe allergic reactions. Patients should report signs of infection, unusual bleeding, persistent fever, or respiratory symptoms promptly.
Who should not use Leukeran?+
Leukeran is contraindicated in patients with known hypersensitivity to chlorambucil or other alkylating agents, those with severe bone‑marrow suppression, active uncontrolled infections, or pregnant women unless the benefits outweigh the risks. It should also be used with caution in individuals with significant liver impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Chlorambucil
Route
Oral Use
Manufacturer
Aspen Pharma Trading Limited
Origin
EU

Related products

Leukeran 2 mg

Leukeran 2 mg

Chlorambucil · 2 MG

Leukeran
TABLET
ASPEN PHARMACARE CANADA INC.
CANADA
Chlorambucil Aspen

Chlorambucil Aspen

Chlorambucil

Aspen Pharma Trading Limited
EU
Chloraminophene

Chloraminophene

Chlorambucil

Techni-Pharma
EU
Clorambucilo Aspen

Clorambucilo Aspen

Chlorambucil

Aspen Pharma Trading Limited
EU